A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 39,100 shares of MRVI stock, worth $177,905. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,100
Previous 21,800 79.36%
Holding current value
$177,905
Previous $156,000 107.69%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.87 - $11.34 $600,341 - $990,957
87,386 Added 32.35%
357,549 $2.56 Million
Q1 2024

May 15, 2024

SELL
$5.11 - $8.76 $4.47 Million - $7.67 Million
-875,519 Reduced 76.42%
270,163 $2.34 Million
Q4 2023

Feb 14, 2024

SELL
$4.7 - $9.87 $2.9 Million - $6.08 Million
-616,448 Reduced 34.98%
1,145,682 $7.5 Million
Q3 2023

Nov 14, 2023

BUY
$9.14 - $12.85 $16 Million - $22.4 Million
1,745,774 Added 10673.6%
1,762,130 $17.6 Million
Q2 2023

Aug 14, 2023

SELL
$12.09 - $15.0 $6.1 Million - $7.56 Million
-504,201 Reduced 96.86%
16,356 $203,000
Q1 2023

May 15, 2023

BUY
$12.99 - $16.48 $315,332 - $400,052
24,275 Added 4.89%
520,557 $7.29 Million
Q4 2022

Feb 14, 2023

SELL
$12.5 - $24.78 $16.6 Million - $32.9 Million
-1,327,883 Reduced 72.79%
496,282 $7.1 Million
Q3 2022

Nov 14, 2022

BUY
$20.6 - $30.37 $34.8 Million - $51.3 Million
1,687,956 Added 1239.24%
1,824,165 $46.6 Million
Q2 2022

Aug 15, 2022

SELL
$26.05 - $37.48 $7.78 Million - $11.2 Million
-298,682 Reduced 68.68%
136,209 $3.87 Million
Q1 2022

May 16, 2022

BUY
$24.46 - $40.92 $4.59 Million - $7.68 Million
187,588 Added 75.85%
434,891 $15.3 Million
Q4 2021

Feb 14, 2022

SELL
$35.0 - $45.94 $37.5 Million - $49.2 Million
-1,070,096 Reduced 81.23%
247,303 $10.4 Million
Q3 2021

Nov 15, 2021

BUY
$36.8 - $60.62 $24.1 Million - $39.7 Million
655,686 Added 99.09%
1,317,399 $64.7 Million
Q2 2021

Aug 16, 2021

BUY
$32.46 - $45.0 $11.1 Million - $15.4 Million
341,175 Added 106.44%
661,713 $27.6 Million
Q1 2021

May 17, 2021

SELL
$25.8 - $38.49 $22 Million - $32.8 Million
-852,991 Reduced 72.69%
320,538 $11.4 Million
Q4 2020

Feb 16, 2021

BUY
$24.5 - $30.86 $28.8 Million - $36.2 Million
1,173,529 New
1,173,529 $32.9 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $599M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.